Federal Trade Commission Approves Administrative Complaint Against Supplement Marketer Health Research Laboratories, LLC


WASHINGTON, Nov. 21 -- The Federal Trade Commission issued the following news release on Nov. 20:

The Federal Trade Commission has approved a Part 3 administrative complaint against dietary supplement marketer Health Research Laboratories, LLC (HRL), its owner and officer Kramer Duhon, and Whole Body Supplements, LLC (WBS) for making unsubstantiated claims that their supplements-The Ultimate Heart Formula (UHF), BG18, and Black Garlic Botanicals-prevent or treat cardiovascular and other diseases, and that their supplement Neupathic cures, mitigates, or treats diabetic neuropathy.

In December 2019, FTC staff and the State of Maine filed a contempt motion against HRL, Duhon, and WBS in federal district court for violating a January 2018 stipulated final order.

According to the contempt motion, after agreeing to the 2018 order prohibiting unsubstantiated health claims, the defendants violated its terms by making unsubstantiated claims about UHF, BG18, Black Garlic Botanicals, and Neupathic.

Earlier this year, a court issued an order denying the FTC's contempt motion. Staff then discontinued further contempt proceedings, and the FTC issued the administrative complaint announced today. The complaint is scheduled to be heard before an administrative law judge in July 2021. The Commission vote authorizing the administrative complaint was 5-0.


Related Businesses
    - - Customer

    Copyright © 2020 by CreditRiskMonitor.com (Ticker: CRMZ®). All rights reserved.  You are not permitted to use this report or the information contained herein for any purpose not expressly permitted by CreditRiskMonitor.com, Inc. Except as expressly permitted by CreditRiskMonitor.com, Inc., you are not permitted, in whole or in part, to copy, alter, correct, adapt, translate, enhance, lease, sell, sublicense, assign, distribute, publish, otherwise make available to any third party, or prepare derivative works or improvements of this report or any of the information contained therein. You are not permitted to reverse engineer, disassemble, decompile, decode, or adapt the software, algorithms or other processes used to prepare this report, or otherwise attempt to derive or gain access to the source code of same. You agree not to remove, alter, obscure, combine or otherwise change any disclaimers, trademarks, copyrights, other intellectual property rights, proprietary rights, or other symbols, notices, marks, or serial numbers on or relating to any copy of the report or on marketing or other materials that CreditRiskMonitor.com, Inc. may provide to you. You will not use this report in any manner or for any purpose that infringes, misappropriates, or otherwise violates any right of any party, or that violates any applicable law.  
    The FRISK® scores, agency ratings, credit limit recommendations and other scores, analysis and commentary are opinions of CreditRiskMonitor.com, Inc. and/or its suppliers, not statements of fact, and should be one of several factors in making credit decisions.  Any reliance you place on the information in this report is strictly at your own risk. Except as expressly provided by CreditRiskMonitor.com, Inc., no warranties or representations of any type, including without limitation of results to be obtained, merchantability or fitness for a particular purpose, are made concerning any part of CreditRiskMonitor.com, Inc.’s service, including without limitation the FRISK® scores.  The information published above has been obtained from sources CreditRiskMonitor considers to be reliable.  CreditRiskMonitor.com, Inc. and its third-party suppliers do not guarantee or validate the accuracy and completeness of the information provided in this report, the underlying information input to create the FRISK® scores, and specifically do not assume responsibility for not reporting any information omitted or withheld.  By using this website, you accept the Terms of Use Agreement
    Contact Us: 845.230.3000
    Fundamental financial data concerning public companies may be provided by Refinitiv (click for restrictions)
    Saturday, November 28, 2020